At a glance
ClinicalIndex Comparison RecordN/ACompleted· 23 enrolled
Drug / intervention
The continuous glucose monitoring systemdevice
Likely dose
Continuous glucose monitoring via CGM device (Dexcom G6) worn on back of arm with readings displayed on smartphoneAI-extracted
Key inclusion· 4
- ✓Prediabetes confirmed by finger prick blood A1C
- ✓CDC prediabetes risk test score of 5 or higher
- ✓Willingness to wear CGM sensor
- ✓Member of or working with Latino community
Key exclusion· 5
- ✕Pregnant
- ✕Age less than 18 years
- ✕Any disorder that interferes with glucose metabolism
- ✕Significant medical condition or event affecting ability to participate
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diabetes Prevention Combining CGM and Artificial Intelligence Health Education
In Brief
A clinical study evaluating The continuous glucose monitoring system for Pre-diabetes. Completed, enrolled 23 participants across 1 site.
Detailed Summary
The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPre-diabetes
CountriesUnited States
Timeline
N/ACompletedFinished
20252026
Enrollment StartJun 2024
First PostedJun 2024
Primary CompletionSep 2024
TodayJul 2026
First PostedJun 25, 2024
Enrollment StartJun 1, 2024
Primary CompletionSep 30, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.0 years ago
Interventions
The continuous glucose monitoring systemdevice
CGM device worn on back of the arm and glucose readings are shown on the participant's smartphone as a continuous data stream.